First leukaemia patient to get new form of treatment on NHS says it is ‘very sci-fi’

Oscar Murphy, a patient suffering from an aggressive form of leukaemia, has become the first individual in the United Kingdom to receive CAR-T cell therapy through the National Health Service. This innovative treatment, described by Murphy as “very sci-fi,” represents a significant step forward in combating challenging blood cancers. CAR-T therapy involves genetically modifying a patient’s own immune cells to specifically target and destroy cancer cells. For patients with aggressive forms of leukaemia that have been resistant to conventional treatments, this specialized immunotherapy offers a new and potentially life-changing option. The introduction of CAR-T therapy on the NHS marks a crucial development in cancer care across the country, providing hope for improved outcomes for those with limited alternative treatments. Medical professionals are closely observing the results of this advanced procedure, anticipating its impact on the future landscape of oncology.